WAEPS - Monthly Scientific Meetings
Presented jointly with the Univ. of Washington Department of Ophthalmology
Join your colleagues for a monthly learning session presented by top experts in a variety of ophthalmology sub-specialties. Program is held at the 7th Floor Conference Room in the 9th and Jefferson Building (908 Jefferson St.) in Seattle from 6:30 p.m. to 8:30 p.m. In addition, the series is available to members throughout the state via webinar. Be sure to register online on this page of the WAEPS website and you will automatically receive an email with login instructions. Or contact the WAEPS office: waeps@waeps.org
Schedule:
Check in and light refreshments: 6:00 p.m.
Presentations at 6:30 and 7:30 p.m.
WAEPS members may self-register online for each month’s program using the link on this page. Your automatic confirmation email will contain the webinar login information for that month’s session. If you need assistance with registration or do not receive your confirmation, please contact the WAEPS office no later than 3 p.m. on the day of the session you plan to participate in. Contact [email protected] or call 206-956-3650.
Credit for the series is an exclusive WAEPS member benefit and free of charge. Members in good standing of neighboring states' ophthalmology societies may also be eligible. Check with the WAEPS office for details.
CME Info: Note that to earn CME credit you must track your attendance and submit a credit claim form at the end of the series and you must sign in to each session you attend. More details will be made available when you register. Click here to download the form for the 2019-20 series.
Attention California Ophthalmologists: If you are registering from California, please contact your Society Executive VP Craig Kliger to register. Do not register via the WAEPS online tool.
If you participated in a previous year's series and have a question about your CME credit, please contact Kimberly Conn, WAEPS Executive Director: [email protected] or phone: 206-956-3652.
(Requires Member Login)
2019-20 Monthly Scientific Meeting Series:
Future programs:
October 23, 2019
Y. Joyce Liao, MD, PhD
The Monthly Meeting is in the 7th Floor Conference Room in the 9th and Jefferson Building (908 Jefferson St.)
Associate Professor Director
Neuro-Ophthalmology, Department of Ophthalmology
Stanford University School of Medicine
Disclosures: Dr. Liao has no ACCME-defined commercial interests. Her presentation will be evidence based and free of bias.
Dr. Liao has no relationships with ACCME-defined commercial interests. Her presentation will be evidence based and free of bias.
Lecture 1: Never Show Fear: Tales of Eye-Brain Diseases
Objectives – after participating in this activity, the attendees should be able to:
- Understand how to approach neuro-ophthalmic emergencies
- Learn not to miss symptoms and signs in eye-brain diseases
- Learn how to interact with patients with eye-brain diseases and make the next right steps.
Lecture 2: Reading Difficulties in Eye-Brain Diseases
Objectives – after participating in this activity, the attendees should be able to:
- Learn about the simple ways reading abilities can be assessed in the eye clinic
- Understand the ocular motor abilities and patterns necessary to read and how this is affected in eye-brain diseases
- Understand how reading is affected in patients with visual field loss, ocular motor issues, and Parkinson's disease.
November 20, 2019
Robert C. Kersten, MD
The R&T Building at Harborview is closed for a contamination issue. The Monthly Meeting has been moved to the 7th Floor Conference Room in the 9th and Jefferson Building (908 Jefferson St.)
Chief of the Division of Ocular Plastics and Reconstructive Surgery
Oculoplastic specialist
UCSF Health
Disclosures: Dr. Kersten has no ACCME-defined commercial interests. His presentation will be evidence based and free of bias.
Dr. Kersten has no relationships with ACCME-defined commercial interests. His presentation will be evidence based and free of bias.
Lecture 1: Periocular penetrating trauma- more than a "Poke in the eye with a sharp stick"
Objectives – after participating in this activity, the attendees should be able to:
- Identify mechanisms of injury leading to penetrating trauma
- Identify signs and symptoms suggesting deeper problem penetration
- Understand options for intervention and repair.
Lecture 2: Oculoplastic case studies- coming soon to a patient near you
Objectives – after participating in this activity, the attendees should be able to:
- Indications for intervention in orbital hemorrhage
- Natural history of dermis cysts
- History of the clinical trial.
December 18, 2019
Matthew Zhang, MD
The R&T Building at Harborview is closed for a contamination issue. The Monthly Meeting has been moved to the 7th Floor Conference Room in the 9th and Jefferson Building (908 Jefferson St.)
Assistant Professor
Department of Ophthalmology
University of Washington
Disclosures: Dr. Zhang has no ACCME-defined commercial interests. His presentation will be evidence based and free of bias.
Dr. Zhang has no relationships with ACCME-defined commercial interests. His presentation will be evidence based and free of bias.
Lecture 1: Thyroid Eye Disease: Utilization of Orbital Radiotherapy(ORT)
Objectives – after participating in this activity, the attendees should be able to:
- Recognize TED
- Know the indications of ORT in the setting of TED
- Be familiar with the evidence for ORT in the treatment of TED.
Lecture 2: Canalicular Injury and Reconstruction
Objectives – after participating in this activity, the attendees should be able to:
- Understand anatomy canalicular anatomy
- Understand the pathophyisiology of canalicular trauma
- Understand the basics of canalicular trauma repair.
January 8, 2020
Donald J. D'Amico, MD, FACS
The R&T Building at Harborview is closed for a contamination issue. The Monthly Meeting has been moved to the 7th Floor Conference Room in the 9th and Jefferson Building (908 Jefferson St.)
The John Milton McLean Professor and Chairman Ophthalmologist-in-Chief
Weill Cornell Medicine Ophthalmology
Disclosures: Dr. D'Amico has no ACCME-defined commercial interests. His presentation will be evidence based and free of bias.
Dr. D'Amico has no relationships with ACCME-defined commercial interests. His presentation will be evidence based and free of bias.
Lecture 1: Advances and Controversies in the Management of Primary Retinal Detachment
Objectives – after participating in this activity, the attendees should be able to:
- Discuss the options for treatment of primary retinal detachment
- Be informed as to changing trends in the management of primary retinal detachment
- Understand the prognosis for visual recovery with various forms of retinal detachment.
Lecture 2: Navigating Treatment Options for Macular Edema
Objectives – after participating in this activity, the attendees should be able to:
- Discuss the options for treatment of macular edema from several etiologies
- Be informed as to failed management approaches which should no longer be attempted
- Understand the prognosis for visual recovery with various forms of macular edema.
February 19, 2020
Phoebe Lin, MD, PhD
The R&T Building at Harborview is closed for a contamination issue. The Monthly Meeting has been moved to the 7th Floor Conference Room in the 9th and Jefferson Building (908 Jefferson St.)
Associate Professor of Ophthalmology Retinal and Vitreous Diseases/SurgeryOcular inflammation
Casey Eye Institute Oregon Health & Science University
Disclosures: Dr. Lin has no ACCME-defined commercial interests. Her presentation will be evidence based and free of bias.
Dr. Lin has no relationships with ACCME-defined commercial interests. Her presentation will be evidence based and free of bias.
Lecture 1: Diagnostic biopsies
Objectives – after participating in this activity, the attendees should be able to:
- Recognize indications for ocular diagnostic biopsies
- Identify potential complications for ocular diagnostic biopsies
- Learn about yield of diagnostic vitrectomy.
Lecture 2: When to use local vs. systemic therapy for non-infectious uveitis
Objectives – after participating in this activity, the attendees should be able to:
- Recognize types of local vs. systemic therapies for uveitis
- Identify indications for local vs. systemic therapy for uveitis
- Learn about complex algorithms for treatment of non-infectious uveitis.
March 25, 2020
Eric Pierce, MD, PhD
The R&T Building at Harborview is closed for a contamination issue. The Monthly Meeting has been moved to the 7th Floor Conference Room in the 9th and Jefferson Building (908 Jefferson St.)
Professor
Massachusetts Eye and Ear Infirmary
Disclosures: Dr. Pierce has no ACCME-defined commercial interests. His presentation will be evidence based and free of bias.
Dr. Pierce has no relationships with ACCME-defined commercial interests. His presentation will be evidence based and free of bias.
Lecture 1: Genetics of Inherited Retinal Degenerations
Objectives – after participating in this activity, the attendees should be able to:
- Have a better understanding of the genetic causality of inherited retinal degenerations.
Lecture 2: Clinical Translation of Genetic Therapies for Inherited Retinal Degenerations
Objectives – after participating in this activity, the attendees should be able to:
- Be better informed regarding clinical use of genetic therapies for inherited retinal degenerations.
April 29, 2020
Kathryn Colby, MD, PhD
The R&T Building at Harborview is closed for a contamination issue. The Monthly Meeting has been moved to the 7th Floor Conference Room in the 9th and Jefferson Building (908 Jefferson St.)
Louis Block Professor Chair
Department of Ophthalmology and Visual Science
The University of Chicago Medicine & Biological Science
Disclosures: Dr. Colby has no ACCME-defined commercial interests. Her presentation will be evidence based and free of bias.
Dr. Colby has no relationships with ACCME-defined commercial interests. Her presentation will be evidence based and free of bias.
Lecture 1: ontroversies in the Diagnosis and Management of Ocular Surface Tumors
Objectives – after participating in this activity, the attendees should be able to:
- Have a better understanding of At the completion of this activity, the learner will be able to identify clinical features of various ocular surface lesions that confer risk for malignancy
- At the completion of this activity, the learner will be able to describe optimal surgical techniques for the management of ocular surface tumors
- At the completion of this activity, the learner will be able to describe the indications for topical chemotherapy in the treatment of ocular surface tumors, as well as the risks and benefits of the different types of chemotherapy.
Lecture 2: Update on Cornea Surgery
Objectives – after participating in this activity, the attendees should be able to:
- Describe the current indications for corneal transplantation in the US, as well as the different transplantation techniques currently performed
- Describe the current surgical approaches for management of endothelial dysfunction and will be able to describe the advantages and disadvantages of each approach
- Describe the indications for keratoprosthesis (artificial cornea) surgery, surgical techniques, and management of post-operative complications.
May 20, 2020
Steven J. Gedde, MD
The R&T Building at Harborview is closed for a contamination issue. The Monthly Meeting has been moved to the 7th Floor Conference Room in the 9th and Jefferson Building (908 Jefferson St.)
Professor of Ophthalmology and John G. Clarkson Chair Vice Chairman of Education and Residency Program Director
Bascom Palmer Eye Institute
Disclosures: Dr. Gebbe has no ACCME-defined commercial interests. His presentation will be evidence based and free of bias.
Dr. Gebbe has no relationships with ACCME-defined commercial interests. His presentation will be evidence based and free of bias.
Lecture 1: The(R)evolution in Glaucoma Surgery
Objectives – after participating in this activity, the attendees should be able to:
- Discuss the indications of incisional glaucoma surgery
- Identify traditional glaucoma procedures used in the surgical management of glaucoma
- Describe newer procedures classified as minimally invasive glaucoma surgery (MIGS).
Lecture 2: Lessions learned from Glaucoma Clinical Trials
Objectives – after participating in this activity, the attendees should be able to:
- Describe the study designs of several multicenter clinical trials in glaucoma
- Discuss the major findings of recent clinical trials in glaucoma
- Apply results of glaucoma clinical trials to patient care.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Washington School of Medicine and Washington Academy of Eye Physicians and Surgeons. The University of Washington School of Medicine is accredited by the ACCME to provide continuing medical education for physicians
The University of Washington School of Medicine designates this live activity for a maximum of 16.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 2.0 credits)
Planning Committee Disclosures:
Committee member Dr. Aaron Lee, MD, PhD, has no relevant commercial interests to disclose.
Committee member Dr. Russell Van Gelder has no relevant commercial interests to disclose.
To view an archive of past Monthly WAEPS Scientific Meetings, please click here. Please note, you must be logged in to access the archive page.
|
